Investors who held FLOW cryptocurrency between December 27 and December 29, 2025, are being urged to contact the Rosen Law Firm. The firm is currently investigating potential securities claims against the Flow Foundation, alleging the organization disseminated materially misleading business information to the public.
The Orbis Flying Eye Hospital has touched down in Arequipa, Peru, launching a two-week intensive training program for local medical professionals. In collaboration with the Ministry of Health and Hospital Regional Honorio Delgado Espinoza, the mission aims to bolster ophthalmic care across the country’s southern, often underserved, regions.
A 22% plunge in Disc Medicine’s stock price on February 13, 2026, has triggered a formal investigation by Rosen Law Firm. The legal action centers on allegations that the biotech company misled shareholders regarding the viability of its bitopertin drug program, which recently failed to secure FDA approval.
Nearly 90% of confirmed Ebola cases in the Democratic Republic of Congo are concentrated in the Ituri Province, prompting Samaritan's Purse to launch two emergency field hospitals. These facilities in Bunia and Nyankunde aim to isolate patients and provide urgent care as the viral outbreak continues to climb.
At 8:30 a.m. on Monday, June 15, 2026, the team at Tradr ETFs will ring the Opening Bell at Cboe Global Markets. The ceremony marks the debut of the Tradr 2X Long SpaceX Daily ETF (SPCM) and the Tradr 2X Short SpaceX Daily ETF (SPCG), both designed for high-conviction, short-term trading.
The combination of selinexor and ruxolitinib has met a primary endpoint in the Phase 3 SENTRY trial, demonstrating a statistically significant reduction in spleen volume for patients with frontline myelofibrosis. Presented at the EHA 2026 Congress, the results highlight a potential shift in treatment efficacy for this rare blood cancer.
Adding Eli Lilly’s pirtobrutinib to a standard venetoclax and rituximab regimen significantly improved outcomes for patients with relapsed or refractory chronic lymphocytic leukemia, according to results from the Phase 3 BRUIN CLL-322 trial presented ahead of the 2026 European Hematology Association Annual Meeting.
Investors who sustained losses exceeding $100,000 in Zillow Group stock have until August 10, 2026, to file lead plaintiff applications. The class action lawsuit, pending in the Western District of Washington, centers on allegations that the company obscured the true nature of its agreement with Redfin.
Three infants in California, Pennsylvania, and Washington have been hospitalized with botulism, prompting a nationwide recall of Nara Organics Whole Milk Organic Powdered Infant Formula. Health officials identified the product, sold through Target and online, as the source of type A botulinum toxin infections occurring between April and May.
Investors who purchased Babcock & Wilcox Enterprises, Inc. securities between November 5, 2025, and March 11, 2026, have until June 15, 2026, to file as lead plaintiffs in a pending class action lawsuit alleging that the company misled shareholders regarding its financial prospects and contractual relationships.
Investors who purchased POET Technologies Inc. securities between April 1 and April 27, 2026, face a June 29 deadline to petition the court to serve as lead plaintiff in a class action lawsuit alleging securities fraud against the company and its executives.
Employees at Victoria's Secret Stores, LLC are taking the company to court, alleging a systematic failure to provide mandated meal and rest breaks. The class action complaint, filed in Los Angeles County Superior Court, claims the retailer routinely bypassed California labor protections to avoid paying required wages and penalties.
Standing before a crowd of parents and educators outside the San Diego campus on June 12, Margaretta Boutserse launched a wrongful termination suit against Albert Einstein Academies. The veteran principal alleges she was fired after refusing to undermine teacher unionization efforts, a demand she claims violated California law.
A 10.5% drop in TruBridge stock on March 17, 2026, followed the company’s admission that it could not file its annual report due to significant accounting errors. The firm is now the subject of a securities class action investigation led by the Rosen Law Firm, which alleges the company misled shareholders.
Under the glow of the Huangpu River, the 28th Shanghai International Film Festival launched today, marking the start of a week-long celebration of global cinema. The event, one of only 17 FIAPF-accredited competitive festivals worldwide, drew industry luminaries to a city now hosting over 1,600 screenings through June 20.
Investors who purchased Verra Mobility common stock between February 24 and May 26, 2026, are now eligible to join a securities fraud class action. The lawsuit, filed in the U.S. District Court for the District of Arizona, follows a sharp decline in share price triggered by the loss of a major contract.
At the European Society of Human Genetics conference in Gothenburg, MGI Tech is pivoting toward a collaborative model, launching a partner enablement program to integrate its sequencing platforms directly into clinical diagnostic workflows while opening its automation technology to original equipment manufacturers.
With $123 million in total commitments, Kos Biotechnology Partners has finalized the third closing of its inaugural fund, marking the largest venture capital launch in Greek history. The firm, operating out of New York and Athens, aims to bridge the gap between American drug development expertise and European scientific talent.
The United States, Canada, and Mexico dominate the 2026 global ranking of top amusement park destinations, as immersive storytelling and large-scale entertainment districts increasingly define international tourism. This index, compiled by Travel and Tour World, highlights how entertainment-driven travel is shaping consumer preferences across North America, Europe, and Asia.
Eli Lilly and Company is presenting Phase 1 clinical findings for AJ1-11095, a first-in-class type II JAK2 inhibitor, at the 2026 European Hematology Association Annual Meeting in Stockholm. The drug targets patients with myelofibrosis who have previously failed to respond to standard type I JAK2 therapies.
As modern lifestyles and environmental factors increasingly challenge metabolic balance, Manassas-based PureHealth Research is positioning a new collection of supplements to address thyroid health. The company is leaning into consumer demand for proactive wellness by emphasizing specific minerals and botanicals designed to support endocrine function and daily energy levels.
As environmental stressors and aging increasingly impact renal efficiency, Manassas-based PureHealth Research is launching a line of supplements aimed at bolstering the body’s natural filtration system. The formulas rely on a blend of turmeric, magnesium, and probiotics to assist in fluid regulation and cellular waste management.
Investors who purchased PicS N.V. Class A common stock following the company’s January 30, 2026, IPO are facing a critical deadline. A class action lawsuit, filed in the Southern District of New York, alleges that the firm misled shareholders regarding its credit evaluation procedures and internal financial health.
Patients of the Roseville-based Minnesota Epilepsy Group are facing potential identity theft after a security breach in March 2026 exposed sensitive medical and personal records. The incident has prompted a formal investigation by the national consumer rights firm Wolf Haldenstein Adler Freeman & Herz LLP.
As temperatures rise, homeowners often face a choice between expensive professional installations or settling for subpar outdoor conditions. VEVOR is positioning its new "Beat the Heat" lineup as a middle ground, offering plug-and-play shade, refrigeration, and airflow equipment designed to bypass traditional contractor lead times and high costs.
A 12 percent plunge in Blaize Holdings stock on April 28, 2026, has triggered a formal investigation by the Rosen Law Firm. The inquiry focuses on allegations that the company issued materially misleading business information, specifically concerning a 50 million dollar deal with NeoTensr questioned by short seller Pelican Way Research.
With the M14 PLUS and S14 PLUS dropping to $399.99 starting June 13, YEEDI is aggressively pushing its self-cleaning roller mop technology into the sub-$400 market. This early Prime Day move marks the lowest price points ever for these models, signaling a broader push to make premium automated cleaning accessible.
While the world focuses on this summer’s major football tournament, Ecuador’s tourism board is turning its attention to the game’s missing icons. By placing personalized invitations across Madrid and other global hubs, the country aims to lure sidelined stars—and their millions of followers—to its rainforests and volcanic landscapes.
After 23 nights of illumination across the harbor, Vivid Sydney has officially powered down, cementing its status as the world’s largest comprehensive arts festival. The 2026 iteration drew massive crowds to five key zones, blending high-profile global talent with a renewed focus on local Australian artistry.
In a bid to capture the global spotlight during this summer’s international football tournament, Ecuador’s tourism board is bypassing the pitch to reach the game’s biggest names. The campaign specifically targets high-profile players who missed the tournament roster, inviting them to spend their unexpected time off in the Andean nation.
